Related Experiment Video
Updated: Mar 23, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
PTEN: History of a Tumor Suppressor
1Department of Pharmacology and Toxicology, University of Toronto, Princess Margaret Cancer Centre, Room 4211, Medical Sciences Building, 1 King's College Circle, Toronto, ON, Canada, M5S 1A8. leonardo.salmena@utoronto.ca.
Abstract:
Starting from the discovery of "inhibitory chromosomes" by Theodor Boveri to the finding by Henry Harris that fusing a normal cell to a cancer cell reduced tumorigenic potential, the notion of tumor suppression was recognized well before any tumor-suppressor genes were discovered. Although not the first to be revealed, PTEN has been demonstrated to be one of the most frequently altered tumor suppressors in cancer. This introductory chapter provides a historical perspective on our current understanding of PTEN including some of the seminal discoveries in the tumor suppressor field, the events leading to PTEN's discovery, and an introduction to some of the most important researchers and their studies which have shed light on PTEN biology and function as we know it today.
Insights
Tumor suppression, the concept of inhibiting cancer cell growth, was recognized before specific genes were identified. This chapter reviews the history of tumor suppressor discoveries, focusing on the phosphatase and tensin homolog (PTEN) gene, a key player in cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The concept of tumor suppression predates the identification of specific tumor suppressor genes.
- Early experiments, such as cell fusion studies, indicated the presence of factors that could inhibit tumor growth.
- Phosphatase and tensin homolog (PTEN) is a critical tumor suppressor frequently altered in various cancers.
Observation:
- PTEN (Phosphatase and tensin homolog) is a critical tumor suppressor gene.
- PTEN is among the most frequently altered tumor suppressors identified in various cancers.
- Its alterations significantly impact cancer development and progression.
Findings:
- This chapter traces the historical discoveries leading to the identification of PTEN.
- It highlights seminal research in the tumor suppressor field.
- Key researchers and their studies elucidating PTEN biology and function are introduced.
Implications:
- Understanding PTEN's historical context is crucial for current cancer research.
- Elucidating PTEN's role provides insights into novel therapeutic strategies.
- The historical perspective informs future investigations into tumor suppression mechanisms.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...